Stoke Therapeutics Non Current Liabilities Other Over Time
| STOK Stock | USD 11.91 0.14 1.19% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Stoke Therapeutics Performance and Stoke Therapeutics Correlation. Stoke |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Revenue Per Share 0.328 | Quarterly Revenue Growth 0.479 | Return On Assets (0.28) | Return On Equity (0.52) |
The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Current Liabilities Other Analysis
Compare Stoke Therapeutics and related stocks such as Ikena Oncology, Eliem Therapeutics, and HCW Biologics Non Current Liabilities Other Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IKNA | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 12.8 M | 3.8 M | 950 K | 902.5 K |
| HCWB | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 14.3 K | 12.8 K | 11.4 K |
| SCPH | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 7 K | 52 K | 159 K | 58 K | 219 K | 367 K | 35 K | 177 K | 147.7 K |
| MIST | 696 K | 696 K | 696 K | 696 K | 696 K | 696 K | 696 K | 696 K | 696 K | 696 K | 696 K | 474 K | 474 K | 426.6 K | 468 K |
| MCRB | 586 K | 586 K | 586 K | 586 K | 586 K | 586 K | 107.5 M | 95 M | 124.3 M | 110.1 M | 97.1 M | 116.5 M | 201.8 M | 1.6 M | 1.5 M |
| LUMO | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 82 K | 82 K | 82 K | 82 K | 82 K | 73.8 K | 70.1 K |
Stoke Therapeutics and related stocks such as Ikena Oncology, Eliem Therapeutics, and HCW Biologics Non Current Liabilities Other description
My Equities
My Current Equities and Potential Positions
| Stoke Therapeutics | STOK |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 11.91
Check out Stoke Therapeutics Performance and Stoke Therapeutics Correlation. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Stoke Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.